O

ORENGO A. M.

Last name: ORENGO A. M.

2017 (v1)

Publication

Metadata-only

18F-Fluorodeoxyglucose Imaging of Inflammation: Ready to Represent a Standard in Diagnosing Endocarditis?

Sambuceti G. Morbelli S. Orengo A. M.

No description

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Two high-rate pentose-phosphate pathways in cancer cells

Cossu V. Bonanomi M. Bauckneht M.

The relevant role of pentose phosphate pathway (PPP) in cancer metabolic reprogramming has been usually outlined by studying glucose-6-phosphate dehydrogenase (G6PD). However, recent evidence suggests an unexpected role for a less characterized PPP, triggered by hexose-6-phosphate dehydrogenase (H6PD) within the endoplasmic reticulum (ER)....

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?

Sambuceti G. Cossu V. Bauckneht M.

No description

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

Metformin and cancer glucose metabolism: At the bench or at the bedside?

Marini C. Cossu V. Bauckneht M.

Several studies reported that metformin, the most widely used drug for type 2 diabetes, might affect cancer aggressiveness. The biguanide seems to directly impair cancer energy asset, with the consequent phosphorylation of AMP-activated protein kinase (AMPK) inhibiting cell proliferation and tumor growth. This action is most often attributed to...

Uploaded on: April 14, 2023